Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Top Cited Papers
Open Access
- 29 May 2014
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (11), 2913-2921
- https://doi.org/10.1158/0008-5472.can-14-0155
Abstract
Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the average annual percentage changes in incidence and death rates. Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, respectively. Lung cancer is projected to remain the top cancer killer throughout this time period. However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, respectively. Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future. Cancer Res; 74(11); 2913–21. ©2014 AACR.This publication has 15 references indexed in Scilit:
- Pancreatic Cancer Death Rates by Race Among US Men and Women, 1970–2009JNCI Journal of the National Cancer Institute, 2013
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineThe New England Journal of Medicine, 2013
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsJNCI Journal of the National Cancer Institute, 2013
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Overdiagnosis in CancerJNCI Journal of the National Cancer Institute, 2010
- Deconstructing the Drug Development Process: The New Face of InnovationClinical Pharmacology & Therapeutics, 2010
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing NationJournal of Clinical Oncology, 2009
- Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2008
- Translational Research Working Group Developmental Pathway for Biospecimen-Based Assessment ModalitiesClinical Cancer Research, 2008